Charles Schwab Investment Management Inc. Trims Stock Position in Seer, Inc. (NASDAQ:SEER)

Charles Schwab Investment Management Inc. lessened its stake in Seer, Inc. (NASDAQ:SEER) by 91.9% in the 3rd quarter, HoldingsChannel.com reports. The fund owned 17,867 shares of the company’s stock after selling 203,094 shares during the period. Charles Schwab Investment Management Inc.’s holdings in Seer were worth $35,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds also recently made changes to their positions in the company. AQR Capital Management LLC purchased a new stake in shares of Seer in the 2nd quarter valued at about $30,000. Point72 DIFC Ltd acquired a new position in Seer during the second quarter worth approximately $35,000. American Century Companies Inc. increased its position in Seer by 42.1% during the second quarter. American Century Companies Inc. now owns 61,752 shares of the company’s stock worth $104,000 after buying an additional 18,302 shares during the period. Cubist Systematic Strategies LLC purchased a new stake in Seer in the second quarter valued at approximately $133,000. Finally, Point72 Asia Singapore Pte. Ltd. acquired a new stake in shares of Seer in the second quarter valued at approximately $148,000. Hedge funds and other institutional investors own 75.20% of the company’s stock.

Seer Trading Down 0.4 %

Shares of SEER opened at $2.31 on Friday. The company’s 50 day simple moving average is $2.24 and its 200-day simple moving average is $1.93. Seer, Inc. has a 12-month low of $1.51 and a 12-month high of $2.63. The firm has a market cap of $136.21 million, a PE ratio of -1.78 and a beta of 1.58.

Seer Profile

Seer, Inc, a life sciences company, engages in developing and commercializing products to decode the biology of the proteome. It develops Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only.